WallStreetZenWallStreetZen

NASDAQ: AGIO
Agios Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Agios Pharmaceuticals earnings were -$422.6M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest AGIO earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$99.1M, down 8.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, AGIO reported annual earnings of -$412.8M, with -161.3% growth.

AGIO earnings history

Current Revenue
$66.0M
Current Earnings
-$422.6M
Current Profit Margin
-639.8%

AGIO Return on Equity

Current Company
-34.1%
Current Industry
-5.4%
Current Market
12.2%
AGIO's Return on Equity (-34.1%)... subscribe to Premium to read more.
High Return on Equity Performance

AGIO Return on Assets

Current Company
-31.7%
Current Industry
-14.9%
AGIO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when AGIO announces earnings.

AGIO Return on Capital Employed

Current Company
-37.62%
Current Industry
-10%
AGIO's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AGIO vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AGIO-$405.69M-$422.60MN/A-$7.25
SNDX-$204.80M-$243.25MN/A-$2.79
ARDX-$31.67M-$58.06MN/A-$0.24
NBTX-$8.31M-$27.54MN/A-$0.58
INVA$383.79M$271.17M+12.71%$4.02
View Top Biotech Stocks

Agios Pharmaceuticals Earnings Reports & History FAQ

What were Agios Pharmaceuticals's earnings last quarter?

Agios Pharmaceuticals (NASDAQ: AGIO) reported Q1 2026 earnings per share (EPS) of -$1.69, up 9.03% year over year. Total AGIO earnings for the quarter were -$99.11 million. In the same quarter last year, Agios Pharmaceuticals's earnings per share (EPS) was -$1.55.

If you're new to stock investing, here's how to buy Agios Pharmaceuticals stock.

Is Agios Pharmaceuticals profitable or losing money?

As of the last Agios Pharmaceuticals earnings report, Agios Pharmaceuticals is currently losing money. Agios Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$422.60 million, a 163.46% decrease year over year.

What was AGIO's earnings growth in the past year?

As of Agios Pharmaceuticals's earnings date in Q2 2026, Agios Pharmaceuticals's earnings has grown year over year. AGIO earnings in the past year totalled -$422.60 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.